Clinical Scorecard: Impact of Intraoperative Neuromonitoring on Quality of Life and Functional Outcomes Following Microsurgical Resection of Cervical and Thoracic Intramedullary Spinal Cord Tumors in Adults

At a Glance

Key Highlights

• IMSCTs comprise 2-4% of CNS neoplasms and 20-30% of spinal cord tumors in adults.
• Radical resection is associated with increased survival and long-term progression-free survival.
• Prospective study evaluates neurological, functional, and QoL outcomes post-surgery.
• Detailed assessments include MRC grading, SF-36v2, and Barthel Index.
• Best postoperative status achieved at median 12 months post-surgery.

Guideline-Based Recommendations

Diagnosis

• Use preoperative contrast-enhanced MR imaging for tumor characterization.

Management

• Perform multimodal intraoperative neuromonitoring during microsurgical resection.

Monitoring & Follow-up

• Assess neurological status, daily-life function, and QoL at multiple follow-up intervals.

Risks

• Monitor for new or worsened sensorimotor deficits, pain, and gait ataxia postoperatively.

Patient & Prescribing Data

Adults referred for IMSCT resection.

Preoperative steroids administered; total intravenous anesthesia used.

Clinical Best Practices

• Utilize a multidimensional approach for patient evaluation pre- and post-surgery.
• Incorporate both gross-functional and detailed neurological assessments.

Related Resources & Content

• Study on IMSCTs